Interventions to make primary care diagnoses faster and safer
Part of Blood & lymphatic clinical trials.
This trial tests a set of practice changes in primary care to improve diagnostic safety (making sure the right diagnosis is found) and efficiency (reducing time and delays). It may help patients who have certain lab results suggesting kidney function concerns and low hemoglobin (low blood level).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are cared for in one of the participating primary care clinics when the study starts
- Your last available blood hemoglobin is low: under 10.8 for females or under 12.5 for males
- Your white blood cell and platelet counts are normal, and prior related results were normal within the last 2 years
- Your kidney function screening test is low: eGFR under 60, and prior eGFR and matching creatinine were normal within the last 2 years
- You are not pregnant and you can speak English or Spanish
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how well an integrated program for identifying and treating people at risk for chronic kidney disease (CKD) can improve outcomes. It may help by catching problems earlier and guiding treatment sooner.
This trial tests whether extra support for ICU doctors and nurses helps them follow recommended guidelines for preventing and treating anemia (low red blood cells) in intensive care. It aims to improve patient outcomes by ensuring best practices are used.
This trial tests a drug called luspatercept to see if it can raise hemoglobin levels in people with anemia caused by chronic kidney disease. It's for those whose current treatments aren't working well or who cannot use them.
This study tests a program to help Black patients with advanced kidney disease learn about their condition and treatment options. It aims to see if this learning program can improve health outcomes.
This trial uses genetic testing to find the cause of rare kidney diseases. It is for people with unexplained kidney problems, a family history of kidney disease, or certain findings on ultrasound. The goal is to provide a more personalized diagnosis and see if this approach is cost-effective.
This study tests whether a new care plan for people with diabetes and kidney disease can reduce the risk of serious heart and kidney events. It aims to improve outcomes by closely following patients in routine care.
Hear when a new Anemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.